22671-29-0
22671-29-0
Chemical Structure
L-Hexanoylcarnitine
- CAS. Nr.: 22671-29-0
- Formula:C13H25NO4
- Molecular Weight:259.34
IUPAC Name: (R)-3-(hexanoyloxy)-4-(trimethylammonio)butanoate
InChIKey: VVPRQWTYSNDTEA-LLVKDONJSA-N
SMILES: CCCCCC(O[C@H](CC([O-])=O)C[N+](C)(C)C)=O
Biological Activity: L-Hexanoylcarnitine is an acylcarnitine and is found to be associated with celiac disease.
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L-Hexanoylcarnitine | 99.87% | L-Hexanoylcarnitine is an acylcarnitine and is found to be associated with celiac disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Hexanoylcarnitine (Standard) | ≥98% | L-Hexanoylcarnitine (Standard) is the analytical standard of L-Hexanoylcarnitine. This product is intended for research and analytical applications. L-Hexanoylcarnitine is an acylcarnitine and also a urinary biomarker for hyperlipidemia. The expression of L-Hexanoylcarnitine is upregulated in colorectal cancer cells, which is associated with metabolic pathways related to cell growth and proliferation. L-Hexanoylcarnitine can be used in studies related to hyperlipidemia and stage B colorectal cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Hexanoylcarnitine-d9 | L-Hexanoylcarnitine-d9 is deuterium labeled L-Hexanoylcarnitine. L-Hexanoylcarnitine is an acylcarnitine and also a urinary biomarker for hyperlipidemia. The expression of L-Hexanoylcarnitine is upregulated in colorectal cancer cells, which is associated with metabolic pathways related to cell growth and proliferation. L-Hexanoylcarnitine can be used in studies related to hyperlipidemia and stage B colorectal cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
